Blog
Aetion® Generate Expands with Replicate, Protect, and Enhance
Purpose-Built Solutions to Secure, Scale, and Strengthen Real-World Data Utility
Blog
Real-World Evidence at Scale: Aetion® Launches in AWS Marketplace
Healthcare decisions depend on defensible, timely evidence. From regulatory filings to ...
Blog
Ensuring Accuracy in Real-World Epidemiology: How Aetion® Substantiate Delivers Reliable Prevalence and Incidence Estimates
Ashley Jaksa, MPH, Natalie Schibell, MPH, and Pippa Hodgkins Aetion® Substantiate: A ...
Blog
Quantifying Disease Burden with Confidence: Prevalence and Incidence Analytics in Aetion® Discover
Natalie Schibell, MPH, Pippa Hodgkins, and Abby Case Aetion® Discover: A Solution for ...
Blog
Real-World Evidence in Action: Supporting Regulatory Advancements in Robotic-Assisted Surgery
The National Evaluation System for Health Technology (NEST) Coordinating Center was ...
Blog
De-Identification in Healthcare: The Legal and Strategic Imperative for Global Compliance
Lucy Mosquera, MS, and Natalie Schibell, MPH The regulatory landscape for real-world data ...
Blog
Decision-Ready Evidence, Any Data Model, No Compromises
Real-world data (RWD) exists in multiple formats—claims, electronic health records, ...
Blog
Shaping the Future of IBD Drug Development with Real-World Data
Michelle Skornicki, MPH, Natalie Schibell, MPH, and Rohan Shah Inflammatory bowel disease ...
Blog
Elevating Cohort Analysis with Population Exploration in Substantiate
Natalie Schibell, MPH and Pippa Hodgkins As healthcare systems navigate increasingly ...
Blog
Real-World Evidence in Medical Device Approvals: Strengthening the Path to Regulatory Success
Expanding the Role of Real-World Evidence in Medical Device Regulation Regulatory ...
Blog
Enterprise RWE Adoption: Aetion’s Maturity Model for Integration and Leadership
Ashley Jaksa, MPH and Natalie Schibell, MPH Real-World Evidence (RWE) has evolved from ...
Blog
Aetion Recognized as a Leader in CB Insights’ Synthetic Patient Data Market Analysis
Aetion has been named a Leader in CB Insights’ Synthetic Patient Data Market Analysis, ...
Blog
One Year of Aetion® Discover: Driving Innovation in Real-World Evidence Generation
Real-world data (RWD) presents significant complexities that require solutions that blend ...
Blog
Aetion® Substantiate Spotlight: Turning Dosing Complexity Into Actions
Michelle Skornicki, MPH; Natalie Schibell, MPH; Pippa Hodgkins; Renee Sajedian Evaluating ...
Blog
2024 in Review: Aetion’s Impact on Real-World Evidence Generation
In 2024, Aetion continued to redefine real-world evidence (RWE) generation by combining ...
Blog
Advancing Evidence: Insights from the 43rd Annual J.P. Morgan Healthcare Conference
The 43rd Annual J.P. Morgan Healthcare Conference provided a platform for thoughtful ...
Blog
Custom Analyses: Elevating Aetion® Substantiate’s Capabilities for Tailored Research
Blog
Key Takeaways from the 43rd Annual J.P. Morgan Healthcare Conference
The 43rd Annual J.P. Morgan Healthcare Conference, held from January 13-16, 2025, in San ...
Blog
Aetion Generate 3.6: Privacy Meets Scientific Rigor in Real-World Evidence
At Aetion®, we ensure privacy concerns and compliance hurdles never stand in the way of ...
Blog
Feature Spotlight: Transforming RWD Management with Measures Assistant (Beta)
Real-world data (RWD) is the lifeblood of modern healthcare research, driving ...
Blog
FDA Expands Dupixent Approval for Adolescents with Chronic Rhinosinusitis with Nasal Polyps, Leveraging RWE Powered by Aetion® Substantiate
Blog authored by:
Blog
Driving Innovation in HTA Decision-Making: Aetion participates in RWE4Decisions' 2024 Stakeholder Actions
On November 14th, RWE4Decisions hosted its annual Symposium, this year focusing on how to ...
Blog
Own the Future of Healthcare: Aetion’s AI/ML Tools Turn Data Into Impact
Healthcare stands at a crossroads. The pressure to deliver better care at lower costs is ...
Blog
Applying AI to RWE and Drug Development
With applications abound, AI is poised to change how RWD/RWE teams operate and how ...